1. Home
  2. MOGO vs AKTX Comparison

MOGO vs AKTX Comparison

Compare MOGO & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOGO
  • AKTX
  • Stock Information
  • Founded
  • MOGO 2003
  • AKTX N/A
  • Country
  • MOGO Canada
  • AKTX United States
  • Employees
  • MOGO N/A
  • AKTX 12
  • Industry
  • MOGO
  • AKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MOGO
  • AKTX Health Care
  • Exchange
  • MOGO Nasdaq
  • AKTX Nasdaq
  • Market Cap
  • MOGO 32.5M
  • AKTX 32.8M
  • IPO Year
  • MOGO N/A
  • AKTX N/A
  • Fundamental
  • Price
  • MOGO $1.27
  • AKTX $1.24
  • Analyst Decision
  • MOGO Strong Buy
  • AKTX
  • Analyst Count
  • MOGO 1
  • AKTX 0
  • Target Price
  • MOGO $6.00
  • AKTX N/A
  • AVG Volume (30 Days)
  • MOGO 64.3K
  • AKTX 25.4K
  • Earning Date
  • MOGO 03-19-2025
  • AKTX 02-15-2025
  • Dividend Yield
  • MOGO N/A
  • AKTX N/A
  • EPS Growth
  • MOGO N/A
  • AKTX N/A
  • EPS
  • MOGO N/A
  • AKTX N/A
  • Revenue
  • MOGO $30,995,226.00
  • AKTX N/A
  • Revenue This Year
  • MOGO N/A
  • AKTX N/A
  • Revenue Next Year
  • MOGO $3.73
  • AKTX N/A
  • P/E Ratio
  • MOGO N/A
  • AKTX N/A
  • Revenue Growth
  • MOGO N/A
  • AKTX N/A
  • 52 Week Low
  • MOGO $0.94
  • AKTX $0.90
  • 52 Week High
  • MOGO $2.25
  • AKTX $4.40
  • Technical
  • Relative Strength Index (RSI)
  • MOGO 44.79
  • AKTX 51.97
  • Support Level
  • MOGO $1.16
  • AKTX $1.10
  • Resistance Level
  • MOGO $1.34
  • AKTX $1.39
  • Average True Range (ATR)
  • MOGO 0.07
  • AKTX 0.13
  • MACD
  • MOGO 0.00
  • AKTX -0.00
  • Stochastic Oscillator
  • MOGO 40.48
  • AKTX 61.54

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Share on Social Networks: